Trial intelligence / Profile preview

Effect of Oral Isotretinoin on Ocular Surface in Acne Patients

NCT07753811Completed

Sponsor
Benha University
Start
Jan 2024
Primary completion
Jan 2025
Countries
1
01

Overview

Open-label trial of isotretinoin in acne vulgaris (2 arms), sponsored by Benha University. Primary endpoints: Meibomian Gland Morphology at 6 months and Ocular Surface Disease Index at 6 months. Started Jan 2024; status: completed.

02

Drugs

isotretinoin
03

Conditions

acne vulgaris

Beyond the preview

Go deeper on NCT07753811.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07753811.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call